Global Mesalazine Enteric Coated Tablets Market Growth 2026-2032
The global Mesalazine Enteric Coated Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Mesalazine Enteric Coated Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Mesalazine Enteric Coated Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Mesalazine Enteric Coated Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Mesalazine Enteric Coated Tablets players cover Dr. Falk Pharma GmbH, Astellas Pharma Inc., AbbVie Inc., DSM Pharmaceuticals, Sun Pharmaceutical Industries Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Mesalazine Enteric Coated Tablets Industry Forecast? looks at past sales and reviews total world Mesalazine Enteric Coated Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Mesalazine Enteric Coated Tablets sales for 2026 through 2032. With Mesalazine Enteric Coated Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine Enteric Coated Tablets industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine Enteric Coated Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine Enteric Coated Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mesalazine Enteric Coated Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine Enteric Coated Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine Enteric Coated Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine Enteric Coated Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Mesalazine Enteric Coated Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Mesalazine Enteric Coated Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Mesalazine Enteric Coated Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Mesalazine Enteric Coated Tablets players cover Dr. Falk Pharma GmbH, Astellas Pharma Inc., AbbVie Inc., DSM Pharmaceuticals, Sun Pharmaceutical Industries Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Mesalazine Enteric Coated Tablets Industry Forecast? looks at past sales and reviews total world Mesalazine Enteric Coated Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Mesalazine Enteric Coated Tablets sales for 2026 through 2032. With Mesalazine Enteric Coated Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine Enteric Coated Tablets industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine Enteric Coated Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine Enteric Coated Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mesalazine Enteric Coated Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine Enteric Coated Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine Enteric Coated Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine Enteric Coated Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.25g
- 0.5g
- 1g
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dr. Falk Pharma GmbH
- Astellas Pharma Inc.
- AbbVie Inc.
- DSM Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Fosun Pharma
- Huahai Pharmaceuticals
- UCB Pharma
- CR Sanjiu
- What is the 10-year outlook for the global Mesalazine Enteric Coated Tablets market?
- What factors are driving Mesalazine Enteric Coated Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Mesalazine Enteric Coated Tablets market opportunities vary by end market size?
- How does Mesalazine Enteric Coated Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalazine Enteric Coated Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mesalazine Enteric Coated Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mesalazine Enteric Coated Tablets by Country/Region, 2021, 2025 & 2032
2.2 Mesalazine Enteric Coated Tablets Segment by Type
2.2.1 0.25g
2.2.2 0.5g
2.2.3 1g
2.2.4 Mesalazine Enteric Coated Tablets Sales by Type
2.2.4.1 Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Mesalazine Enteric Coated Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Mesalazine Enteric Coated Tablets Sale Price by Type (2021-2026)
2.3 Mesalazine Enteric Coated Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Mesalazine Enteric Coated Tablets Sales by Application
2.3.4.1 Global Mesalazine Enteric Coated Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Mesalazine Enteric Coated Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Mesalazine Enteric Coated Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mesalazine Enteric Coated Tablets Breakdown Data by Company
3.1.1 Global Mesalazine Enteric Coated Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Mesalazine Enteric Coated Tablets Sales Market Share by Company (2021-2026)
3.2 Global Mesalazine Enteric Coated Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Company (2021-2026)
3.2.2 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Mesalazine Enteric Coated Tablets Sale Price by Company
3.4 Key Manufacturers Mesalazine Enteric Coated Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine Enteric Coated Tablets Product Location Distribution
3.4.2 Players Mesalazine Enteric Coated Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAZINE ENTERIC COATED TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Mesalazine Enteric Coated Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Mesalazine Enteric Coated Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mesalazine Enteric Coated Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mesalazine Enteric Coated Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Mesalazine Enteric Coated Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mesalazine Enteric Coated Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mesalazine Enteric Coated Tablets Sales Growth
4.4 APAC Mesalazine Enteric Coated Tablets Sales Growth
4.5 Europe Mesalazine Enteric Coated Tablets Sales Growth
4.6 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Growth
5 AMERICAS
5.1 Americas Mesalazine Enteric Coated Tablets Sales by Country
5.1.1 Americas Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
5.1.2 Americas Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026)
5.2 Americas Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
5.3 Americas Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine Enteric Coated Tablets Sales by Region
6.1.1 APAC Mesalazine Enteric Coated Tablets Sales by Region (2021-2026)
6.1.2 APAC Mesalazine Enteric Coated Tablets Revenue by Region (2021-2026)
6.2 APAC Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
6.3 APAC Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalazine Enteric Coated Tablets by Country
7.1.1 Europe Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
7.1.2 Europe Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026)
7.2 Europe Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
7.3 Europe Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalazine Enteric Coated Tablets by Country
8.1.1 Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine Enteric Coated Tablets
10.3 Manufacturing Process Analysis of Mesalazine Enteric Coated Tablets
10.4 Industry Chain Structure of Mesalazine Enteric Coated Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine Enteric Coated Tablets Distributors
11.3 Mesalazine Enteric Coated Tablets Customer
12 WORLD FORECAST REVIEW FOR MESALAZINE ENTERIC COATED TABLETS BY GEOGRAPHIC REGION
12.1 Global Mesalazine Enteric Coated Tablets Market Size Forecast by Region
12.1.1 Global Mesalazine Enteric Coated Tablets Forecast by Region (2027-2032)
12.1.2 Global Mesalazine Enteric Coated Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mesalazine Enteric Coated Tablets Forecast by Type (2027-2032)
12.7 Global Mesalazine Enteric Coated Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Dr. Falk Pharma GmbH
13.1.1 Dr. Falk Pharma GmbH Company Information
13.1.2 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.1.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Dr. Falk Pharma GmbH Main Business Overview
13.1.5 Dr. Falk Pharma GmbH Latest Developments
13.2 Astellas Pharma Inc.
13.2.1 Astellas Pharma Inc. Company Information
13.2.2 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.2.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Astellas Pharma Inc. Main Business Overview
13.2.5 Astellas Pharma Inc. Latest Developments
13.3 AbbVie Inc.
13.3.1 AbbVie Inc. Company Information
13.3.2 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.3.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AbbVie Inc. Main Business Overview
13.3.5 AbbVie Inc. Latest Developments
13.4 DSM Pharmaceuticals
13.4.1 DSM Pharmaceuticals Company Information
13.4.2 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.4.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 DSM Pharmaceuticals Main Business Overview
13.4.5 DSM Pharmaceuticals Latest Developments
13.5 Sun Pharmaceutical Industries Ltd.
13.5.1 Sun Pharmaceutical Industries Ltd. Company Information
13.5.2 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.5.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.6 Fosun Pharma
13.6.1 Fosun Pharma Company Information
13.6.2 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.6.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Fosun Pharma Main Business Overview
13.6.5 Fosun Pharma Latest Developments
13.7 Huahai Pharmaceuticals
13.7.1 Huahai Pharmaceuticals Company Information
13.7.2 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.7.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Huahai Pharmaceuticals Main Business Overview
13.7.5 Huahai Pharmaceuticals Latest Developments
13.8 UCB Pharma
13.8.1 UCB Pharma Company Information
13.8.2 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.8.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 UCB Pharma Main Business Overview
13.8.5 UCB Pharma Latest Developments
13.9 CR Sanjiu
13.9.1 CR Sanjiu Company Information
13.9.2 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.9.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CR Sanjiu Main Business Overview
13.9.5 CR Sanjiu Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalazine Enteric Coated Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mesalazine Enteric Coated Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mesalazine Enteric Coated Tablets by Country/Region, 2021, 2025 & 2032
2.2 Mesalazine Enteric Coated Tablets Segment by Type
2.2.1 0.25g
2.2.2 0.5g
2.2.3 1g
2.2.4 Mesalazine Enteric Coated Tablets Sales by Type
2.2.4.1 Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Mesalazine Enteric Coated Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Mesalazine Enteric Coated Tablets Sale Price by Type (2021-2026)
2.3 Mesalazine Enteric Coated Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Mesalazine Enteric Coated Tablets Sales by Application
2.3.4.1 Global Mesalazine Enteric Coated Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Mesalazine Enteric Coated Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Mesalazine Enteric Coated Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mesalazine Enteric Coated Tablets Breakdown Data by Company
3.1.1 Global Mesalazine Enteric Coated Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Mesalazine Enteric Coated Tablets Sales Market Share by Company (2021-2026)
3.2 Global Mesalazine Enteric Coated Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Company (2021-2026)
3.2.2 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Mesalazine Enteric Coated Tablets Sale Price by Company
3.4 Key Manufacturers Mesalazine Enteric Coated Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine Enteric Coated Tablets Product Location Distribution
3.4.2 Players Mesalazine Enteric Coated Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAZINE ENTERIC COATED TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Mesalazine Enteric Coated Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Mesalazine Enteric Coated Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mesalazine Enteric Coated Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mesalazine Enteric Coated Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Mesalazine Enteric Coated Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mesalazine Enteric Coated Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mesalazine Enteric Coated Tablets Sales Growth
4.4 APAC Mesalazine Enteric Coated Tablets Sales Growth
4.5 Europe Mesalazine Enteric Coated Tablets Sales Growth
4.6 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Growth
5 AMERICAS
5.1 Americas Mesalazine Enteric Coated Tablets Sales by Country
5.1.1 Americas Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
5.1.2 Americas Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026)
5.2 Americas Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
5.3 Americas Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine Enteric Coated Tablets Sales by Region
6.1.1 APAC Mesalazine Enteric Coated Tablets Sales by Region (2021-2026)
6.1.2 APAC Mesalazine Enteric Coated Tablets Revenue by Region (2021-2026)
6.2 APAC Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
6.3 APAC Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalazine Enteric Coated Tablets by Country
7.1.1 Europe Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
7.1.2 Europe Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026)
7.2 Europe Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
7.3 Europe Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalazine Enteric Coated Tablets by Country
8.1.1 Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine Enteric Coated Tablets
10.3 Manufacturing Process Analysis of Mesalazine Enteric Coated Tablets
10.4 Industry Chain Structure of Mesalazine Enteric Coated Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine Enteric Coated Tablets Distributors
11.3 Mesalazine Enteric Coated Tablets Customer
12 WORLD FORECAST REVIEW FOR MESALAZINE ENTERIC COATED TABLETS BY GEOGRAPHIC REGION
12.1 Global Mesalazine Enteric Coated Tablets Market Size Forecast by Region
12.1.1 Global Mesalazine Enteric Coated Tablets Forecast by Region (2027-2032)
12.1.2 Global Mesalazine Enteric Coated Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mesalazine Enteric Coated Tablets Forecast by Type (2027-2032)
12.7 Global Mesalazine Enteric Coated Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Dr. Falk Pharma GmbH
13.1.1 Dr. Falk Pharma GmbH Company Information
13.1.2 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.1.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Dr. Falk Pharma GmbH Main Business Overview
13.1.5 Dr. Falk Pharma GmbH Latest Developments
13.2 Astellas Pharma Inc.
13.2.1 Astellas Pharma Inc. Company Information
13.2.2 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.2.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Astellas Pharma Inc. Main Business Overview
13.2.5 Astellas Pharma Inc. Latest Developments
13.3 AbbVie Inc.
13.3.1 AbbVie Inc. Company Information
13.3.2 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.3.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AbbVie Inc. Main Business Overview
13.3.5 AbbVie Inc. Latest Developments
13.4 DSM Pharmaceuticals
13.4.1 DSM Pharmaceuticals Company Information
13.4.2 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.4.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 DSM Pharmaceuticals Main Business Overview
13.4.5 DSM Pharmaceuticals Latest Developments
13.5 Sun Pharmaceutical Industries Ltd.
13.5.1 Sun Pharmaceutical Industries Ltd. Company Information
13.5.2 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.5.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.6 Fosun Pharma
13.6.1 Fosun Pharma Company Information
13.6.2 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.6.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Fosun Pharma Main Business Overview
13.6.5 Fosun Pharma Latest Developments
13.7 Huahai Pharmaceuticals
13.7.1 Huahai Pharmaceuticals Company Information
13.7.2 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.7.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Huahai Pharmaceuticals Main Business Overview
13.7.5 Huahai Pharmaceuticals Latest Developments
13.8 UCB Pharma
13.8.1 UCB Pharma Company Information
13.8.2 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.8.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 UCB Pharma Main Business Overview
13.8.5 UCB Pharma Latest Developments
13.9 CR Sanjiu
13.9.1 CR Sanjiu Company Information
13.9.2 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
13.9.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CR Sanjiu Main Business Overview
13.9.5 CR Sanjiu Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mesalazine Enteric Coated Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mesalazine Enteric Coated Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.25g
Table 4. Major Players of 0.5g
Table 5. Major Players of 1g
Table 6. Global Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 7. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Mesalazine Enteric Coated Tablets Sale Price by Type (2021-2026) & (US$/Ton)
Table 11. Global Mesalazine Enteric Coated Tablets Sale by Application (2021-2026) & (Tons)
Table 12. Global Mesalazine Enteric Coated Tablets Sale Market Share by Application (2021-2026)
Table 13. Global Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & ($ million)
Table 14. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021-2026)
Table 15. Global Mesalazine Enteric Coated Tablets Sale Price by Application (2021-2026) & (US$/Ton)
Table 16. Global Mesalazine Enteric Coated Tablets Sales by Company (2021-2026) & (Tons)
Table 17. Global Mesalazine Enteric Coated Tablets Sales Market Share by Company (2021-2026)
Table 18. Global Mesalazine Enteric Coated Tablets Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Company (2021-2026)
Table 20. Global Mesalazine Enteric Coated Tablets Sale Price by Company (2021-2026) & (US$/Ton)
Table 21. Key Manufacturers Mesalazine Enteric Coated Tablets Producing Area Distribution and Sales Area
Table 22. Players Mesalazine Enteric Coated Tablets Products Offered
Table 23. Mesalazine Enteric Coated Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalazine Enteric Coated Tablets Sales by Geographic Region (2021-2026) & (Tons)
Table 27. Global Mesalazine Enteric Coated Tablets Sales Market Share Geographic Region (2021-2026)
Table 28. Global Mesalazine Enteric Coated Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Mesalazine Enteric Coated Tablets Sales by Country/Region (2021-2026) & (Tons)
Table 31. Global Mesalazine Enteric Coated Tablets Sales Market Share by Country/Region (2021-2026)
Table 32. Global Mesalazine Enteric Coated Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons)
Table 35. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021-2026)
Table 36. Americas Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 38. Americas Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 39. APAC Mesalazine Enteric Coated Tablets Sales by Region (2021-2026) & (Tons)
Table 40. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021-2026)
Table 41. APAC Mesalazine Enteric Coated Tablets Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 43. APAC Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 44. Europe Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons)
Table 45. Europe Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 47. Europe Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 48. Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons)
Table 49. Middle East & Africa Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 51. Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalazine Enteric Coated Tablets
Table 53. Key Market Challenges & Risks of Mesalazine Enteric Coated Tablets
Table 54. Key Industry Trends of Mesalazine Enteric Coated Tablets
Table 55. Mesalazine Enteric Coated Tablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalazine Enteric Coated Tablets Distributors List
Table 58. Mesalazine Enteric Coated Tablets Customer List
Table 59. Global Mesalazine Enteric Coated Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 60. Global Mesalazine Enteric Coated Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Mesalazine Enteric Coated Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 62. Americas Mesalazine Enteric Coated Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Mesalazine Enteric Coated Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 64. APAC Mesalazine Enteric Coated Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Mesalazine Enteric Coated Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 66. Europe Mesalazine Enteric Coated Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Middle East & Africa Mesalazine Enteric Coated Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Mesalazine Enteric Coated Tablets Sales Forecast by Type (2027-2032) & (Tons)
Table 70. Global Mesalazine Enteric Coated Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Mesalazine Enteric Coated Tablets Sales Forecast by Application (2027-2032) & (Tons)
Table 72. Global Mesalazine Enteric Coated Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Dr. Falk Pharma GmbH Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 74. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 75. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 76. Dr. Falk Pharma GmbH Main Business
Table 77. Dr. Falk Pharma GmbH Latest Developments
Table 78. Astellas Pharma Inc. Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 80. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 81. Astellas Pharma Inc. Main Business
Table 82. Astellas Pharma Inc. Latest Developments
Table 83. AbbVie Inc. Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 85. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 86. AbbVie Inc. Main Business
Table 87. AbbVie Inc. Latest Developments
Table 88. DSM Pharmaceuticals Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 90. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. DSM Pharmaceuticals Main Business
Table 92. DSM Pharmaceuticals Latest Developments
Table 93. Sun Pharmaceutical Industries Ltd. Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 95. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Sun Pharmaceutical Industries Ltd. Main Business
Table 97. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 98. Fosun Pharma Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 100. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Fosun Pharma Main Business
Table 102. Fosun Pharma Latest Developments
Table 103. Huahai Pharmaceuticals Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 105. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Huahai Pharmaceuticals Main Business
Table 107. Huahai Pharmaceuticals Latest Developments
Table 108. UCB Pharma Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 110. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. UCB Pharma Main Business
Table 112. UCB Pharma Latest Developments
Table 113. CR Sanjiu Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 115. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 116. CR Sanjiu Main Business
Table 117. CR Sanjiu Latest Developments
Table 1. Mesalazine Enteric Coated Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mesalazine Enteric Coated Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.25g
Table 4. Major Players of 0.5g
Table 5. Major Players of 1g
Table 6. Global Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 7. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Mesalazine Enteric Coated Tablets Sale Price by Type (2021-2026) & (US$/Ton)
Table 11. Global Mesalazine Enteric Coated Tablets Sale by Application (2021-2026) & (Tons)
Table 12. Global Mesalazine Enteric Coated Tablets Sale Market Share by Application (2021-2026)
Table 13. Global Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & ($ million)
Table 14. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021-2026)
Table 15. Global Mesalazine Enteric Coated Tablets Sale Price by Application (2021-2026) & (US$/Ton)
Table 16. Global Mesalazine Enteric Coated Tablets Sales by Company (2021-2026) & (Tons)
Table 17. Global Mesalazine Enteric Coated Tablets Sales Market Share by Company (2021-2026)
Table 18. Global Mesalazine Enteric Coated Tablets Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Company (2021-2026)
Table 20. Global Mesalazine Enteric Coated Tablets Sale Price by Company (2021-2026) & (US$/Ton)
Table 21. Key Manufacturers Mesalazine Enteric Coated Tablets Producing Area Distribution and Sales Area
Table 22. Players Mesalazine Enteric Coated Tablets Products Offered
Table 23. Mesalazine Enteric Coated Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalazine Enteric Coated Tablets Sales by Geographic Region (2021-2026) & (Tons)
Table 27. Global Mesalazine Enteric Coated Tablets Sales Market Share Geographic Region (2021-2026)
Table 28. Global Mesalazine Enteric Coated Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Mesalazine Enteric Coated Tablets Sales by Country/Region (2021-2026) & (Tons)
Table 31. Global Mesalazine Enteric Coated Tablets Sales Market Share by Country/Region (2021-2026)
Table 32. Global Mesalazine Enteric Coated Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons)
Table 35. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021-2026)
Table 36. Americas Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 38. Americas Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 39. APAC Mesalazine Enteric Coated Tablets Sales by Region (2021-2026) & (Tons)
Table 40. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021-2026)
Table 41. APAC Mesalazine Enteric Coated Tablets Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 43. APAC Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 44. Europe Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons)
Table 45. Europe Mesalazine Enteric Coated Tablets Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 47. Europe Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 48. Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons)
Table 49. Middle East & Africa Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons)
Table 51. Middle East & Africa Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalazine Enteric Coated Tablets
Table 53. Key Market Challenges & Risks of Mesalazine Enteric Coated Tablets
Table 54. Key Industry Trends of Mesalazine Enteric Coated Tablets
Table 55. Mesalazine Enteric Coated Tablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalazine Enteric Coated Tablets Distributors List
Table 58. Mesalazine Enteric Coated Tablets Customer List
Table 59. Global Mesalazine Enteric Coated Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 60. Global Mesalazine Enteric Coated Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Mesalazine Enteric Coated Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 62. Americas Mesalazine Enteric Coated Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Mesalazine Enteric Coated Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 64. APAC Mesalazine Enteric Coated Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Mesalazine Enteric Coated Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 66. Europe Mesalazine Enteric Coated Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Middle East & Africa Mesalazine Enteric Coated Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Mesalazine Enteric Coated Tablets Sales Forecast by Type (2027-2032) & (Tons)
Table 70. Global Mesalazine Enteric Coated Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Mesalazine Enteric Coated Tablets Sales Forecast by Application (2027-2032) & (Tons)
Table 72. Global Mesalazine Enteric Coated Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Dr. Falk Pharma GmbH Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 74. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 75. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 76. Dr. Falk Pharma GmbH Main Business
Table 77. Dr. Falk Pharma GmbH Latest Developments
Table 78. Astellas Pharma Inc. Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 80. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 81. Astellas Pharma Inc. Main Business
Table 82. Astellas Pharma Inc. Latest Developments
Table 83. AbbVie Inc. Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 85. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 86. AbbVie Inc. Main Business
Table 87. AbbVie Inc. Latest Developments
Table 88. DSM Pharmaceuticals Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 90. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. DSM Pharmaceuticals Main Business
Table 92. DSM Pharmaceuticals Latest Developments
Table 93. Sun Pharmaceutical Industries Ltd. Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 95. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Sun Pharmaceutical Industries Ltd. Main Business
Table 97. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 98. Fosun Pharma Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 100. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Fosun Pharma Main Business
Table 102. Fosun Pharma Latest Developments
Table 103. Huahai Pharmaceuticals Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 105. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Huahai Pharmaceuticals Main Business
Table 107. Huahai Pharmaceuticals Latest Developments
Table 108. UCB Pharma Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 110. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. UCB Pharma Main Business
Table 112. UCB Pharma Latest Developments
Table 113. CR Sanjiu Basic Information, Mesalazine Enteric Coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolios and Specifications
Table 115. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 116. CR Sanjiu Main Business
Table 117. CR Sanjiu Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mesalazine Enteric Coated Tablets
Figure 2. Mesalazine Enteric Coated Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine Enteric Coated Tablets Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Mesalazine Enteric Coated Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mesalazine Enteric Coated Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mesalazine Enteric Coated Tablets Sales Market Share by Country/Region (2025)
Figure 10. Mesalazine Enteric Coated Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.25g
Figure 12. Product Picture of 0.5g
Figure 13. Product Picture of 1g
Figure 14. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type in 2026
Figure 15. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Mesalazine Enteric Coated Tablets Consumed in Hospital
Figure 17. Global Mesalazine Enteric Coated Tablets Market: Hospital (2021-2026) & (Tons)
Figure 18. Mesalazine Enteric Coated Tablets Consumed in Clinic
Figure 19. Global Mesalazine Enteric Coated Tablets Market: Clinic (2021-2026) & (Tons)
Figure 20. Mesalazine Enteric Coated Tablets Consumed in Others
Figure 21. Global Mesalazine Enteric Coated Tablets Market: Others (2021-2026) & (Tons)
Figure 22. Global Mesalazine Enteric Coated Tablets Sale Market Share by Application (2025)
Figure 23. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application in 2026
Figure 24. Mesalazine Enteric Coated Tablets Sales by Company in 2026 (Tons)
Figure 25. Global Mesalazine Enteric Coated Tablets Sales Market Share by Company in 2026
Figure 26. Mesalazine Enteric Coated Tablets Revenue by Company in 2026 ($ millions)
Figure 27. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Company in 2026
Figure 28. Global Mesalazine Enteric Coated Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 31. Americas Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 32. APAC Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 33. APAC Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 34. Europe Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 35. Europe Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 37. Middle East & Africa Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 38. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Country in 2026
Figure 39. Americas Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021-2026)
Figure 40. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 41. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 42. United States Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Region in 2026
Figure 47. APAC Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021-2026)
Figure 48. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 49. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 50. China Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. India Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Country in 2026
Figure 58. Europe Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021-2026)
Figure 59. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 60. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 61. Germany Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. France Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 69. Egypt Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Mesalazine Enteric Coated Tablets in 2026
Figure 75. Manufacturing Process Analysis of Mesalazine Enteric Coated Tablets
Figure 76. Industry Chain Structure of Mesalazine Enteric Coated Tablets
Figure 77. Channels of Distribution
Figure 78. Global Mesalazine Enteric Coated Tablets Sales Market Forecast by Region (2027-2032)
Figure 79. Global Mesalazine Enteric Coated Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Mesalazine Enteric Coated Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Mesalazine Enteric Coated Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Mesalazine Enteric Coated Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Mesalazine Enteric Coated Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Mesalazine Enteric Coated Tablets
Figure 2. Mesalazine Enteric Coated Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine Enteric Coated Tablets Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Mesalazine Enteric Coated Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mesalazine Enteric Coated Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mesalazine Enteric Coated Tablets Sales Market Share by Country/Region (2025)
Figure 10. Mesalazine Enteric Coated Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.25g
Figure 12. Product Picture of 0.5g
Figure 13. Product Picture of 1g
Figure 14. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type in 2026
Figure 15. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Mesalazine Enteric Coated Tablets Consumed in Hospital
Figure 17. Global Mesalazine Enteric Coated Tablets Market: Hospital (2021-2026) & (Tons)
Figure 18. Mesalazine Enteric Coated Tablets Consumed in Clinic
Figure 19. Global Mesalazine Enteric Coated Tablets Market: Clinic (2021-2026) & (Tons)
Figure 20. Mesalazine Enteric Coated Tablets Consumed in Others
Figure 21. Global Mesalazine Enteric Coated Tablets Market: Others (2021-2026) & (Tons)
Figure 22. Global Mesalazine Enteric Coated Tablets Sale Market Share by Application (2025)
Figure 23. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application in 2026
Figure 24. Mesalazine Enteric Coated Tablets Sales by Company in 2026 (Tons)
Figure 25. Global Mesalazine Enteric Coated Tablets Sales Market Share by Company in 2026
Figure 26. Mesalazine Enteric Coated Tablets Revenue by Company in 2026 ($ millions)
Figure 27. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Company in 2026
Figure 28. Global Mesalazine Enteric Coated Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 31. Americas Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 32. APAC Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 33. APAC Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 34. Europe Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 35. Europe Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Mesalazine Enteric Coated Tablets Sales 2021-2026 (Tons)
Figure 37. Middle East & Africa Mesalazine Enteric Coated Tablets Revenue 2021-2026 ($ millions)
Figure 38. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Country in 2026
Figure 39. Americas Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021-2026)
Figure 40. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 41. Americas Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 42. United States Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Region in 2026
Figure 47. APAC Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021-2026)
Figure 48. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 49. APAC Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 50. China Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. India Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Country in 2026
Figure 58. Europe Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021-2026)
Figure 59. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 60. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 61. Germany Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. France Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026)
Figure 69. Egypt Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Mesalazine Enteric Coated Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Mesalazine Enteric Coated Tablets in 2026
Figure 75. Manufacturing Process Analysis of Mesalazine Enteric Coated Tablets
Figure 76. Industry Chain Structure of Mesalazine Enteric Coated Tablets
Figure 77. Channels of Distribution
Figure 78. Global Mesalazine Enteric Coated Tablets Sales Market Forecast by Region (2027-2032)
Figure 79. Global Mesalazine Enteric Coated Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Mesalazine Enteric Coated Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Mesalazine Enteric Coated Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Mesalazine Enteric Coated Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Mesalazine Enteric Coated Tablets Revenue Market Share Forecast by Application (2027-2032)
